SEC Form 4 · accession 0000891293-18-000072
CTI BIOPHARMA CORP · CTIC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bruce J. Seeley
Officer — EVP, Chief Operating Officer
Period of report
Jun 30, 2018
Accepted (ET)
Jul 2, 2018 · 4:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000891293
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 30, 2018 | A | 500 | $2.295 | A | 31,500 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares acquired under the CTI BioPharma Corp. 2007 Employee Stock Purchase Plan.